Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)
Clinical trial NCT03369665 · COMPLETED
Trial details
- NCT number
- NCT03369665
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-20
- Primary completion
- 2021-11-12
- Enrollment
- 485
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.